PROFILE ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ & ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ financials
PROFILE ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ & ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ
21380051TUVZ3KYK5G44 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €40.1M | €30.1M |
| Cost of sales | €22.4M | €15.5M |
| Gross profit | €17.7M | €14.6M |
| Other income | €1.2M | €932.5K |
| Distribution costs | €4.2M | €4.0M |
| Administrative expenses | €2.7M | €2.5M |
| Operating profit (EBIT) | €7.9M | €5.4M |
| Net finance income / (cost) | -€612.2K | -€237.4K |
| Profit before tax | €7.3M | €5.1M |
| Income tax expense | €1.7M | €1.3M |
| Profit for the year | €5.6M | €3.9M |
| — attributable to owners | €5.6M | €3.9M |
| — attributable to NCI | €515 | -€761 |
| Total comprehensive income | €6.0M | €3.6M |
| Per share | ||
| Basic EPS | €0.23 | €0.16 |
| Diluted EPS | €0.23 | €0.16 |
| Cash flow statement | ||
| Cash generated from operations | €10.7M | €7.9M |
| Net cash from operating activities | €10.4M | €2.1M |
| Income taxes paid | €1.1M | €637.6K |
| Net cash from investing activities | -€2.7M | -€4.5M |
| Net cash from financing activities | €1.7M | -€557.3K |
| Dividends paid | €1.2M | €975.1K |
| Proceeds from borrowings | €4.8M | €0 |
| Repayments of borrowings | €1.3M | €571.4K |
| Lease liability payments | €361.4K | €337.7K |
| Net change in cash | €9.4M | -€3.0M |
| Balance sheet | ||
| Total assets | €67.6M | €55.8M |
| Non-current assets | €21.8M | €20.6M |
| Property, plant & equipment | €4.7M | €5.0M |
| Right-of-use assets | €563.0K | €880.1K |
| Intangible assets & goodwill | €2.0M | €2.1M |
| Current assets | €45.8M | €35.2M |
| Inventories | €129.7K | €919.5K |
| Trade & other receivables | €13.9M | €11.6M |
| Cash & equivalents | €16.7M | €7.3M |
| Total equity | €36.3M | €31.9M |
| — attributable to owners | €36.4M | €32.0M |
| Non-controlling interests | -€108.7K | -€109.2K |
| Non-current liabilities | €5.0M | €2.5M |
| Long-term borrowings | €3.5M | €571.4K |
| Lease liabilities (non-current) | €299.6K | €854.8K |
| Current liabilities | €26.3M | €21.4M |
| Lease liabilities (current) | €306.6K | €81.8K |
| Deferred tax liabilities | €279.8K | €60.7K |
| Derived metrics | ||
| Operating margin | 19.6% | 17.8% |
| Net margin | 13.9% | 12.8% |
| Return on equity | 15.4% | 12.1% |
| Cash conversion ratio | 1.86× | 0.53× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €789.8K | -€826.6K |
| Adjustments For Decrease Increase In Trade Account Receivable | -€3.2M | -€8.0M |
| Adjustments For Depreciation and Amortisation Expense | €2.5M | €2.0M |
| Adjustments For Finance Costs | €664.6K | €406.1K |
| Adjustments For Increase Decrease In Trade Account Payable | €4.2M | €4.5M |
| Adjustments For Provisions | €354.0K | €679.3K |
| Adjustments For Sharebased Payments | €89.6K | €211.2K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €153.7K | -€338.2K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €0 | €0 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €508 | -€830 |
| Comprehensive Income Attributable To Owners of Parent | €6.0M | €3.6M |
| Current Advances To Suppliers | €1.3M | €773.8K |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €6.0M | €5.6M |
| Current Investments | €4.5M | €4.9M |
| Current Payables On Social Security and Taxes Other Than Income Tax | €2.6M | €1.6M |
| Current Tax Liabilities Current | €1.1M | €1.4M |
| Deferred Tax Assets | €490.4K | €344.1K |
| Dividends Received Classified As Investing Activities | €0 | €0 |
| Dividends Recognised As Distributions To Owners of Parent | €1.2M | €975.1K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€17.2K | €124.3K |
| Equity and Liabilities | €67.6M | €55.8M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€4.8K | -€4.2K |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €89.6K | €211.2K |
| Increase Decrease Through Transfer To Statutory Reserve | €0 | — |
| Intangible Assets Other Than Goodwill | €13.8M | €12.1M |
| Interest Paid Classified As Operating Activities | €907.9K | €753.3K |
| Interest Received Classified As Investing Activities | €285.7K | €380.8K |
| Investment Income | €0 | €0 |
| Investments In Subsidiaries Joint Ventures and Associates | €0 | €0 |
| Issue of Equity | €135.6K | €177.4K |
| Issued Capital | €5.7M | €5.7M |
| Liabilities | €31.3M | €23.9M |
| Noncurrent Government Grants | €247.5K | €221.1K |
| Noncurrent Provisions | €41.6K | €52.3K |
| Noncurrent Provisions For Employee Benefits | €603.8K | €722.9K |
| Other Adjustments For Noncash Items | -€193.4K | -€134.6K |
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | -€59.5K | -€55.9K |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €3.1M | €2.3M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €3.7M | €1.4M |
| Other Comprehensive Income | €373.8K | -€221.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€22.0K | -€19.2K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €390.9K | -€206.0K |
| Other Current Payables | €14.2M | €9.1M |
| Other Current Receivables | €9.3M | €9.7M |
| Other Expense By Function | €1.5M | €989.6K |
| Other Noncurrent Financial Assets | €175.6K | €174.4K |
| Other Noncurrent Financial Liabilities | €0 | €0 |
| Other Reserves | €15.7M | €14.1M |
| Payments To and On Behalf of Employees | €138.7K | €97.6K |
| Proceeds From Government Grants Classified As Financing Activities | €186.8K | €149.7K |
| Proceeds From Issuing Shares | €135.6K | €177.4K |
| Proceeds From Sale Or Issue of Treasury Shares | -€558.2K | €999.9K |
| Purchase of Treasury Shares | €586.5K | €483.6K |
| Research and Development Expense | €2.7M | €2.7M |
| Retained Earnings | €13.0M | €9.7M |
| Sale Or Issue of Treasury Shares | — | €1.5M |
| Share Premium | €2.9M | €2.8M |
| Trade and Other Payables To Trade Suppliers | €2.1M | €3.7M |
| Treasury Shares | €900.1K | €313.6K |
Every line item above is a fact tagged in PROFILE ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ & ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.